What Healthcare Investors Get Wrong About Practice Revenue

Quick Answer

Healthcare investors most commonly get practice revenue wrong in three ways: they treat provider-generated revenue as organizationally owned rather than individually generated, they model payer mix quality as static when it is structurally dynamic, and they underestimate how fragile revenue cycle performance is to ownership transitions. All three mistakes are identifiable with EHR-level data before close and require specific structural remedies — employment agreements, payer mix trajectory analysis, and revenue cycle continuity planning — that financial diligence alone won't surface.

Mistake 1: Treating Provider Revenue as Practice Revenue

The single most common and most expensive error in healthcare practice investment is buying the practice when you should be buying the physician relationships. Revenue in a medical practice is not generated by the organization — it is generated by individual physicians whose clinical training, patient relationships, and referral networks are personal assets, not organizational ones.

When a physician retires, leaves, or reduces hours, the revenue they generated does not stay in the practice. It follows them — or, more often, it disappears entirely if the departing physician doesn't have a successor who has built comparable relationships with the same patient population.

This is structurally different from most businesses that investors acquire. In a manufacturing company, a plant manager's departure doesn't eliminate the plant's production capacity. In a medical practice, a physician's departure eliminates that physician's patient panel, the referral relationships that sent patients to that physician, and the payer contracts that were predicated in part on that physician's credentialing.

The data-first approach to this problem is straightforward: pull 36 months of wRVU production by provider. Identify the providers whose individual production accounts for more than 20% of total practice revenue. For each of those providers, assess the combination of age, employment agreement term, non-compete structure, and expressed retention interest. Model the revenue impact of each provider's departure explicitly.

Healthcare due diligence analytics built around encounter-level data makes this analysis precise rather than impressionistic. The question isn't "what happens if a key physician leaves?" — it's "what is the specific revenue at risk from each of the three physicians whose departure would be most consequential, and what deal structures protect against that risk?"

The Employment Agreement Problem

Many practices run on employment agreements with two-year initial terms and sixty-day notice provisions. The practice's most valuable physicians may be twelve months from the end of their current agreement when the deal closes. This is not a problem that appears in the financial statements; it is a problem that appears in the physician roster with agreement end dates.

Retention agreements executed before close, longer initial employment terms tied to compensation structures that incentivize continued production, and non-compete agreements calibrated for the relevant market are not optional post-close — they are structural prerequisites for the revenue model to survive.

Mistake 2: Modeling Payer Mix as Static

Payer mix in a medical practice changes over time — sometimes gradually, sometimes rapidly — and the direction of change has direct implications for revenue. Practices located in economically shifting areas, practices whose referring physician base is aging, and practices that have been growing by filling capacity with lower-acuity or lower-reimbursing patients are all experiencing payer mix change that their current-year financials represent as a snapshot.

The mistake is modeling forward revenue by applying current payer mix percentages and current reimbursement rates to projected volume. This model is accurate if payer mix is stable. It is systematically wrong if payer mix is shifting — in either direction.

The specific patterns worth watching:

Commercial-to-Medicare shift. As an established patient panel ages, commercially insured patients age into Medicare coverage. For specialties where commercial reimbursement substantially exceeds Medicare reimbursement — which is most outpatient specialties — a practice whose patient panel is aging will experience persistent reimbursement rate compression without any change in volume. The financial statements show stable or growing collections until the compression is large enough to be unmistakable; the payer mix trend shows it 12-24 months earlier.

Volume-filling with Medicaid. Practices that have been losing commercial referrals — either because the health system relationship that drove referrals has changed, or because a competitive entrant has absorbed some of the commercial volume — sometimes fill the scheduling gap with Medicaid volume. This maintains encounter count and even grows it, while compressing revenue per encounter significantly. A practice showing 8% volume growth with 3% revenue growth is probably describing exactly this pattern.

Managed care contract expirations. Commercial payer contracts typically have 2-3 year terms. A practice whose most favorable payer contract renews eighteen months after close is about to have a renegotiation conversation under new ownership, potentially with limited leverage if the practice's referral network has declined or competitor practices have taken share. Contract expiration calendars belong in the diligence file alongside financial statements.

Mistake 3: Underestimating Revenue Cycle Transition Risk

Revenue cycle performance in a medical practice is highly dependent on people and relationships — the billing staff who know the payer-specific quirks, the credentialing coordinator who maintains provider enrollment, the front desk staff who verify insurance and collect copays. Ownership transition disrupts all of these.

The most common post-close revenue cycle deterioration pattern: the practice's billing manager leaves in the first 90 days — either because they chose to, because the new owner restructured the billing department, or because their role was absorbed into a portfolio-level billing shared service — and the revenue cycle performance that was built around their institutional knowledge deteriorates before the new structure is fully operational. By the time the deterioration is visible in collections, it is four to six months post-close and has been compounding for three of those months.

Post-acquisition intelligence analytics exists specifically to provide early warning of this kind of deterioration — establishing a pre-close baseline for collection rate, AR aging, denial rate, and first-pass acceptance rate, then monitoring those metrics against baseline in the first 90-180 days post-close with alerts when any metric moves by more than two percentage points from its pre-close average.

The investors who underwrite revenue cycle transition risk explicitly — with a baseline measurement, a monitoring plan, and a contingency budget for billing support if the transition creates a performance dip — weather this phase significantly better than those who discover the deterioration in a quarterly financial review.

What a Data-First Investment Framework Actually Looks Like

Investors who underwrite healthcare practice acquisitions with EHR-level data analysis do the same financial diligence as everyone else, and then add three analytical layers.

Layer 1: Provider revenue attribution. Quantify which revenue is attributable to which individuals, with what risk profile attached to each person's continued engagement. Build the departure scenarios explicitly into the acquisition model, even if the probability of departure is assessed as low.

Layer 2: Payer mix trajectory. Analyze the 36-month trend in payer mix composition and reimbursement rates per CPT code per payer. Model forward payer mix based on the trend rather than the snapshot. Adjust the revenue projection for the realistic trajectory rather than the current state.

Layer 3: Revenue cycle baseline and transition planning. Establish a measured baseline for the six leading revenue cycle metrics described in the revenue cycle analytics framework. Plan the transition explicitly to maintain that baseline. Budget for billing support if the transition creates a performance gap.

A practice performance score that benchmarks the target practice against MGMA national data and regional peers provides additional context — whether the practice's current performance reflects exceptional execution, average execution of an exceptional opportunity, or mediocre execution of an average opportunity. The distinction matters enormously for the investment thesis.

Planning a healthcare acquisition or evaluating your diligence framework? Schedule a discovery call to discuss what EHR-level data analysis adds to your existing process.

Key Takeaways

• Provider revenue is not practice revenue: clinical revenue is generated by individual physicians whose patient relationships and referral networks are personal — when they leave, the revenue follows them or disappears, not stays.
• Employment agreements are part of the revenue model, not the legal review: a physician at the 85th MGMA productivity percentile whose employment agreement ends fourteen months after close is a revenue risk, not a legal formality.
• Payer mix is a trajectory, not a composition: commercial-to-Medicare aging, Medicaid volume-filling to replace lost commercial referrals, and contract expiration calendars all describe future payer mix — which is what the acquisition is buying, not the current mix.
• Revenue cycle performance is people-dependent and transition-sensitive: the institutional knowledge embedded in billing staff, credentialing coordinators, and front desk teams is not documented and doesn't automatically transfer with the legal entity.
• Baseline measurement before close is the prerequisite for monitoring deterioration post-close: you can't detect a 4-point collection rate decline without knowing what the pre-close collection rate was at the encounter level, by payer.
• The three analytical layers that data-first investors add: provider revenue attribution with departure modeling, payer mix trajectory analysis, and pre-close RCM baseline with post-close monitoring plan.